Company Filing History:
6 out of 42 
2 out of 2 
1 out of 29 Years Active: 1988-2003
Title: The Innovative Journey of Inventor Tomas Fex
Introduction
Tomas Fex, an accomplished inventor based in Lund, Sweden, has made significant contributions to the field of pharmaceutical innovations. With a remarkable track record of nine patents, his work primarily focuses on immunomodulating compounds and their potential applications in treating various medical conditions.
Latest Patents
Among his latest patents, Tomas Fex has developed novel heterocyclic compounds intended for clinical treatment aimed at conditions benefiting from immunomodulation. These include diseases such as rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation issues, systemic lupus erythematosus, and psoriasis. His invention highlights CD80 antagonists, which are capable of inhibiting the interactions between CD80 and CD28. Furthermore, he has described methods for screening compounds that inhibit ligand-induced co-stimulatory receptor internalization pathways in immune-competent human cells. Additionally, his patent discusses a kit for screening and an immunoregulatory drug aimed at blocking the down-modulation of a ligand-induced receptor.
Career Highlights
Throughout his career, Tomas Fex has worked with notable companies in the biotechnology sector, including Active Biotech AB and Trikonex AB. His innovative spirit and dedication to research have positioned him as a valued contributor in the field of immunology.
Collaborations
In his journey, Tomas has collaborated with accomplished individuals such as Gunnar Hedlund and Anders K. Bjork. These partnerships have played an essential role in advancing his research and developing groundbreaking compounds.
Conclusion
Tomas Fex's work exemplifies the impact of innovation in pharmaceuticals, especially in immunology. His inventions not only underscore his expertise but also reflect the potential to improve the quality of life for individuals suffering from various medical conditions. As he continues to push the boundaries of science with his patents, the medical community looks forward to his future contributions.